AI-powered earnings and news diagnosis. Updated regularly.
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
The headlines cover a broad range of healthcare names and ETFs rather than one clear company, making the signal mixed. There are positive developments like leadership changes and analyst upgrades, but nothing points to a single dominant trend you can act on confidently.
Read full analysis →